Dexametasona o hidrocortisona intravenosa como profilaxis de cefalea postpunción dural

Objective: to determine the efficacy of intravenous dexamethasone or hydrocortisone as prophylaxis of post-dural punc-ture headache in patients who underwent surgery from January to December 2018. It was an experimental, descriptive, prospective, cross-sectional and correlational investigation. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Calle Gómez, Marco A., Devonish, Nidia, Gurumendi España, Ingrid Esmeralda, Borja Santillán, Maritza Alexandra
Format: Article
Language:Spanish
Published: 2021
Subjects:
Cefalea postpunción dural
profilaxis
hidrocortisona
dexametasona
pacientes gestantes
anestesia conductiva
Post-dural puncture headache
prophylaxis
hydrocortisone
dexamethasone
pregnant patients
conductive anesthesia
Online Access:https://dialnet.unirioja.es/servlet/oaiart?codigo=8056950
Source:RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 3, 2021, pags. 52-65
Tags: Add Tag
No Tags: Be the first to tag this record
Dexametasona o hidrocortisona intravenosa como profilaxis de cefalea postpunción dural
Summary: Objective: to determine the efficacy of intravenous dexamethasone or hydrocortisone as prophylaxis of post-dural punc-ture headache in patients who underwent surgery from January to December 2018. It was an experimental, descriptive, prospective, cross-sectional and correlational investigation. The sample of elective patients (n = 60) was divided into three groups (A: control (n = 20), B: Hydrocortisone 500mg EV (n = 20) and C: Dexamethasone 16mg EV (n = 20)). Descriptive statistics. Results: statistically, the groups in terms of age (A: 66; B: 57 and C: 44), weight (A: 68 kg; B: 67 and C: 57) and height (A: 158 cm; B: 155 and C: 168) were similar; A 25G Sprotte needle, with ASA I risk, was used in all patients; In the control group (A), symptoms of CPPD were observed in 10% of the patients: orthostatic headache, bilateral headache, neck stiffness, tinnitus, photophobia, diplopia, nausea, vomiting, dizziness and previous lumbar puncture. . In the Hydro-cortisone Group (B) no CPPD symptoms were observed and in the dexamethasone group (C) no CPPD symptoms were observed. The average appearance of symptoms was between 19 to 28 hours later, without any adverse reaction. Conclu-sions: the use of both drugs is equally effective as a prophylaxis of post-dural puncture headache.

Similar Items